Harmony Biosciences appoints Peter Anastasiou as COO; adds Troy Ignelzi to Board

Harmony Biosciences Holdings, Inc.

Peter Anastasiou named SEVP and COO, effective April 2, 2026; resigns from Board.
Troy Ignelzi appointed Class III director, filling vacancy; will serve on Audit and Compensation Committees.
Antonio Gracias will not stand for re-election at 2026 annual meeting; term ends May 14, 2026.
Geno J. Germano nominated for election to Board at 2026 annual meeting.
Anastasiou receives $600K base salary, 55% bonus target, $3.7M option award with 4-year vest.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.